Yamo Pharmaceuticals Receives Investment from Autism Impact Fund to Support Phase 2 Study of L1-79 in Autism Spectrum Disorder
10 nov. 2021 14h00 HE
|
Yamo Pharmaceuticals
New York, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Yamo Pharmaceuticals, LLC, a clinical stage pharmaceutical company developing a novel therapy for the core symptoms of the autism spectrum disorder (ASD),...
Autism Spectrum Disorder Therapeutics Market worth USD 5.15 Billion by 2028 | Market Projection By Technology, Major key players, Growth, Revenue, CAGR, Regional Analysis, Industry Forecast To 2028
29 oct. 2021 05h28 HE
|
Fortune Business Insights
Pune, India, Oct. 29, 2021 (GLOBE NEWSWIRE) -- The global autism spectrum disorder therapeutics market size is expected to be worth USD 5.15 billion by 2028. The market size was USD 3.62 billion in...
Hyperbaric Oxygen Therapy Market size worth $ 4.79 Billion, Globally, by 2028 at 6.24% CAGR: Verified Market Research®
23 sept. 2021 10h00 HE
|
Verified Market Research
Jersey City, New Jersey, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Verified Market Research recently published a report, “Hyperbaric Oxygen Therapy Market” By Product Type (Monoplace HBOT, Topical HBOT,...
Autism Spectrum Disorder Therapeutics Market Projected to Hit USD 4,612.1 Million and Surge at 4.3% CAGR by 2026; Awareness Campaigns Conducted to Spread Awareness Regarding the Condition to Propel Growth, Says Fortune Business Insights™
04 mars 2021 05h00 HE
|
Fortune Business Insights
Pune, India, March 04, 2021 (GLOBE NEWSWIRE) -- According to a report published by Fortune Business Insights, titled, “Autism Spectrum Disorder Therapeutics Market”: Global Market Analysis, Insights...
Sierra School of East Valley Marks Specialized Education Services, Inc. (SESI) Eighth California Location
04 janv. 2021 17h27 HE
|
Specialized Education Services, Inc.
COLTON, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Specialized Education Services, Inc. (SESI), a premier provider of education services for K-12 students who require additional educational and...
Dorney Park & Wildwater Kingdom Achieves Certified Autism Center™ Designation
02 oct. 2019 06h45 HE
|
Dorney Park & Wildwater Kingdom
Allentown, PA, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Dorney Park & Wildwater Kingdom has earned the Certified Autism Center™ (CAC) designation, granted by the International Board of Credentialing...
Autism Spectrum Disorder Therapeutics Market to Reach US$ 4,612.1 Mn by 2026; Rising Prevalence of the Condition to Boost Growth, says Fortune Business Insights
26 août 2019 06h10 HE
|
Fortune Business Insights
Pune, Aug. 26, 2019 (GLOBE NEWSWIRE) -- According to a report published by Fortune Business Insights, titled, “Autism Spectrum Disorder Therapeutics Market: Global Market Analysis, Insights and...
Yamo Pharmaceuticals Presents Results from Phase 2 Study of L1-79 in Adolescents and Young Adult Males with Autism Spectrum Disorder at INSAR 2019
14 mai 2019 08h01 HE
|
Yamo Pharmaceuticals
New York , May 14, 2019 (GLOBE NEWSWIRE) -- Yamo Pharmaceuticals, LLC, a clinical stage pharmaceutical company developing a novel therapy for autism spectrum disorder (ASD), announced the...
Cognoa Licenses Innovative Digital Therapeutic Technology
10 avr. 2019 09h04 HE
|
Cognoa
PALO ALTO, Calif., April 10, 2019 (GLOBE NEWSWIRE) -- Cognoa, a company at the forefront of digital behavioral health for children, today announces it has exclusively licensed technology from the...
Cognoa Receives FDA Breakthrough Designations for Autism Diagnostic and Digital Therapeutic Devices
06 févr. 2019 09h04 HE
|
Cognoa
PALO ALTO, Calif., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Cognoa, a company at the forefront of digital behavioral health for children, today announces it has received Breakthrough Device designations...